CoChat
Sign Up
Cited by 5

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Management of Adult Patients with Gastrointestinal Symptoms from Food Hypersensitivity—Narrative Review

Kanikowska, Alina, Janisz, Susanne, Mańkowska-Wierzbicka, Dorota, Gabryel, Marcin, Dobrowolska, Agnieszka, Eder, Piotr·2022·Journal of Clinical Medicine
DOI 10.3390/jcm11247326PMC PMC9784954
Open this paper in CoChat — free account

Abstract

The incidence of food hypersensitivity has increased dramatically over the years not only among children but also in adults. Adult patients are usually less suspected of food hypersensitivity symptoms since food allergies are more typical for small children, with a tendency to outgrow the condition. The aim of this article is to increase awareness of hypersensitivity to food symptoms and their diagnosis and treatment possibilities among gastroenterologists and other health care professionals dealing with this type of patient. Symptoms of many gastrointestinal disorders, especially functional, may be driven by different types of mechanisms, and food intolerance or allergy should be considered as a potential cause. This article presents the current understanding of the epidemiology, diagnosis and treatment of immune- and non-immune-mediated food-induced diseases. Diagnosis of food hypersensitivity is based mainly on medical history, different types of sensitivity tests, e.g., hydrogen breath test, specific IgE (sIgE) serum concentration, tissue eosinophil count, skin tests and oral food challenges considered as a “gold standard” for food allergy. Elimination diet and pharmacologic treatment for allergy symptoms are first-line therapies. Eosinophilic gastrointestinal diseases are often caused by non-IgE-mediated food allergies, require endoscopic biopsy samples to confirm diagnosis and proper elimination diet often combined with steroids or proton pump inhibitor agents for treatment. Mast cell activation syndrome (MCAS) derives from pathologic reaction of mast cells with increased tryptase serum level as a marker. Symptoms may occur in the digestive, respiratory, skin, neurologic and cardiovascular system. Treatment is based on histamine type 1, type 2 (H1, H2) receptor antagonists and other mast cell stabilizing agents. Carbohydrate intolerances are the most common type of food hypersensitivity in adult patients, and an elimination diet is effective for reducing symptoms. Food additives hypersensitivity remains difficult to diagnose, but use of a diet low in chemical substances alleviates symptoms and helps to diagnose the triggering factors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jcm11247326

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 83

  1. Sicherer, 2018, Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management, J. Allergy Clin. Immunol., 141, 41, 10.1016/j.jaci.2017.11.003 · DOI
  2. Acevedo, N., Alashkar Alhamwe, B., Caraballo, L., Ding, M., Ferrante, A., Garn, H., Garssen, J., Hii, C.S., Irvine, J., and Llinás-Caballero, K. (2021). Perinatal and Early-Life Nutrition, Epigenetics, and Allergy. Nutrients, 13. · DOI
  3. Deckers, 2019, How a farming environment protects from atopy, Curr. Opin. Immunol., 60, 163, 10.1016/j.coi.2019.08.001 · DOI
  4. Cañas, J.A., Núñez, R., Cruz-Amaya, A., Gómez, F., Torres, M.J., Palomares, F., and Mayorga, C. (2021). Epigenetics in Food Allergy and Immunomodulation. Nutrients, 13. · DOI
  5. Luu, 2020, Exploring the Molecular Mechanisms Underlying the Protective Effects of Microbial SCFAs on Intestinal Tolerance and Food Allergy, Front. Immunol., 11, 1225, 10.3389/fimmu.2020.01225 · DOI
  6. Azad, 2015, Infant gut microbiota and food sensitization: Associations in the first year of life, Clin. Exp. Allergy, 45, 632, 10.1111/cea.12487 · DOI
  7. Bunyavanich, 2019, Food allergy and the microbiome: Current understandings and future directions, J. Allergy Clin. Immunol., 144, 1468, 10.1016/j.jaci.2019.10.019 · DOI
  8. Roberts, 2015, Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy, N. Engl. J. Med., 372, 803, 10.1056/NEJMoa1414850 · DOI · Paper page
  9. Martino, 2018, Epigenetic dysregulation of naive CD4+ T-cell activation genes in childhood food allergy, Nat. Commun., 9, 3308, 10.1038/s41467-018-05608-4 · DOI
  10. Krajewski, 2018, Epigenetic Regulation via Altered Histone Acetylation Results in Suppression of Mast Cell Function and Mast Cell-Mediated Food Allergic Responses, Front. Immunol., 9, 2414, 10.3389/fimmu.2018.02414 · DOI
  11. Harb, 2016, Recent developments in epigenetics of pediatric asthma, Curr. Opin. Pediatr., 28, 754, 10.1097/MOP.0000000000000424 · DOI
  12. Misselwitz, 2019, Update on lactose malabsorption and intolerance: Pathogenesis, diagnosis and clinical management, Gut, 68, 2080, 10.1136/gutjnl-2019-318404 · DOI · Paper page
  13. Caio, G. (2022). Non-IgE/Mixed Food Allergies and Functional Gastrointestinal Disorder: A Common Thread between Childhood and Adulthood. Nutrients, 14. · DOI
  14. Johansson, 2004, Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003, J. Allergy Clin. Immunol., 113, 832, 10.1016/j.jaci.2003.12.591 · DOI · Paper page
  15. Sampson, 2014, Food allergy: A practice parameter update—2014, J. Allergy Clin. Immunol., 134, 1016, 10.1016/j.jaci.2014.05.013 · DOI · Paper page
  16. Iweala, 2018, Food Allergy, Curr. Gastroenterol. Rep., 20, 17, 10.1007/s11894-018-0624-y · DOI
  17. Anvari, 2018, IgE-Mediated Food Allergy, Clin. Rev. Allergy Immunol., 57, 244, 10.1007/s12016-018-8710-3 · DOI
  18. Johnston, 2014, The Immunology of Food Allergy, J. Immunol., 192, 2529, 10.4049/jimmunol.1303026 · DOI
  19. Zhang, 2021, Pathophysiology of Non-IgE-Mediated Food Allergy, Immunotargets Ther., 10, 431, 10.2147/ITT.S284821 · DOI
  20. Peters, 2020, Update on food allergy, Pediatr. Allergy Immunol., 32, 647, 10.1111/pai.13443 · DOI
  21. LaHood, 2019, Food Allergy Testing, Clin. Lab. Med., 39, 625, 10.1016/j.cll.2019.07.009 · DOI
  22. Sampson, 1984, Comparison of results of skin tests, RAST, and double-blind, placebo-controlled food challenges in children with atopic dermatitis, J. Allergy Clin. Immunol., 74, 26, 10.1016/0091-6749(84)90083-6 · DOI
  23. Bartuzi, 2017, The diagnosis and management of food allergies. Position paper of the Food Allergy Section the Polish Society of Allergology, Adv. Dermatol. Allergol., 5, 391, 10.5114/ada.2017.71104 · DOI
  24. Seth, 2020, Food Allergy: A Review, Pediatr. Ann., 49, e50, 10.3928/19382359-20191206-01 · DOI
  25. Bahri, 2018, Mast cell activation test in the diagnosis of allergic disease and anaphylaxis, J. Allergy Clin. Immunol., 142, 485, 10.1016/j.jaci.2018.01.043 · DOI
  26. Jappe, 2017, Molecular allergy diagnostic tests: Development and relevance in clinical practice, Allergol. Select, 1, 169, 10.5414/ALX01617E · DOI
  27. Wright, 2015, Clinical Management of Food Allergy, Pediatr. Clin. N. Am., 62, 1409, 10.1016/j.pcl.2015.07.012 · DOI
  28. 2018, Probiotics as treatment for food allergies among pediatric patients: A meta-analysis, World Allergy Organ. J., 11, 25, 10.1186/s40413-018-0204-5 · DOI
  29. Castellazzi, 2013, Probiotics and food allergy, Ital. J. Pediatr., 39, 47, 10.1186/1824-7288-39-47 · DOI
  30. Nurmatov, 2017, Allergen immunotherapy for IgE-mediated food allergy: A systematic review and meta-analysis, Allergy, 72, 1133, 10.1111/all.13124 · DOI
  31. Anvari, S., and Anagnostou, K. (2018). The Nuts and Bolts of Food Immunotherapy: The Future of Food Allergy. Children, 5. · DOI
  32. Burks, 2018, Treatment for food allergy, J. Allergy Clin. Immunol., 141, 1, 10.1016/j.jaci.2017.11.004 · DOI
  33. Erlich, 2022, Peanut allergen powder (Palforzia) for peanut allergy, Am. Fam. Physician, 105, 20
  34. Cox, 2021, Clinical Relevance of Cross-Reactivity in Food Allergy, J. Allergy Clin. Immunol. Pract., 9, 82, 10.1016/j.jaip.2020.09.030 · DOI
  35. Masaki, 2019, Rare presentation of anaphylaxis: Pancake syndrome, BMJ Case Rep., 12, e228854, 10.1136/bcr-2018-228854 · DOI
  36. Fischer, 2016, Clinical spectrum of α-Gal syndrome: From immediate-type to delayed immediate-type reactions to mammalian innards and meat, Allergo J. Int., 25, 55, 10.1007/s40629-016-0099-z · DOI
  37. Schuyler, 2015, Anaphylaxis to the Carbohydrate Side Chain Alpha-gal, Immunol. Allergy Clin. N. Am., 35, 247, 10.1016/j.iac.2015.01.009 · DOI
  38. Pacheco, 2020, Alpha-gal syndrome: Challenges to understanding sensitization and clinical reactions to alpha-gal, Expert Rev. Mol. Diagn., 20, 905, 10.1080/14737159.2020.1792781 · DOI
  39. Foong, 2019, Food-dependent exercise-induced anaphylaxis, Curr. Opin. Allergy Clin. Immunol., 19, 224, 10.1097/ACI.0000000000000531 · DOI
  40. Steinbach, 2018, Eosinophilic Esophagitis and the Eosinophilic Gastrointestinal Diseases: Approach to Diagnosis and Management, J. Allergy Clin. Immunol. Pract., 6, 1483, 10.1016/j.jaip.2018.06.012 · DOI
  41. Monaco, 2022, Association of mast-cell-related conditions with hypermobile syndromes: A review of the literature, Immunol. Res., 70, 419, 10.1007/s12026-022-09280-1 · DOI
  42. Vimalathas, 2018, Integrin αM activation and upregulation on esophageal eosinophils and periostin-mediated eosinophil survival in eosinophilic esophagitis, Immunol. Cell Biol., 96, 426, 10.1111/imcb.12018 · DOI
  43. Prasad, 2007, Prevalence and Predictive Factors of Eosinophilic Esophagitis in Patients Presenting With Dysphagia: A Prospective Study, Am. J. Gastroenterol., 102, 2627, 10.1111/j.1572-0241.2007.01512.x · DOI
  44. Gonsalves, 2020, Diagnosis and treatment of eosinophilic esophagitis, J. Allergy Clin. Immunol., 145, 1, 10.1016/j.jaci.2019.11.011 · DOI
  45. Carr, 2019, Correction to: Eosinophilic esophagitis, Allergy Asthma Clin. Immunol., 15, 22, 10.1186/s13223-019-0336-3 · DOI
  46. Gaballa, 2020, Eosinophilic gastroenteritis presenting as unexplained chronic ab-dominal pain, Cureus, 12, e8640
  47. Turner, 2017, Primary Colonic Eosinophilia and Eosinophilic Colitis in Adults, Am. J. Surg. Pathol., 41, 225, 10.1097/PAS.0000000000000760 · DOI
  48. Cianferoni, 2020, Eosinophilic esophagitis and other eosinophilic disorders of the gastrointestinal tract, Pediatr. Allergy Immunol., 31, 25, 10.1111/pai.13153 · DOI
  49. Visaggi, P., Mariani, L., Pardi, V., Rosi, E., Pugno, C., Bellini, M., Zingone, F., Ghisa, M., Marabotto, E., and Giannini, E. (2021). Dietary Management of Eosinophilic Esophagitis: Tailoring the Approach. Nutrients, 13. · DOI
  50. Lucendo, 2017, Guidelines on eosinophilic esophagitis: Evidence-based statements and recommendations for diagnosis and management in children and adults, United Eur. Gastroenterol. J., 5, 335, 10.1177/2050640616689525 · DOI
  51. Delgado, 2019, Eosinophilic esophagitis: Current concepts in diagnosis and treatment, World J. Gastroenterol., 25, 4598, 10.3748/wjg.v25.i32.4598 · DOI
  52. Reed, 2018, Eosinophilic Esophagitis, Med. Clin. N. Am., 103, 29, 10.1016/j.mcna.2018.08.009 · DOI
  53. Straumann, 2018, Diagnosis and Treatment of Eosinophilic Esophagitis, Gastroenterology, 154, 346, 10.1053/j.gastro.2017.05.066 · DOI
  54. Lucendo, 2020, Pharmacological treatments for eosinophilic esophagitis: Current options and emerging therapies, Expert Rev. Clin. Immunol., 16, 63, 10.1080/1744666X.2019.1705784 · DOI
  55. Impellizzeri, 2019, Eosinophilic colitis: A clinical review, Dig. Liver Dis., 51, 769, 10.1016/j.dld.2019.04.011 · DOI
  56. Popovici, 2020, Eosinophilic Esophagitis: Diagnosis and Current Management, J. Gastrointest. Liver Dis., 29, 85, 10.15403/jgld-768 · DOI
  57. Rached, 2016, Eosinophilic gastroenteritis: Approach to diagnosis and management, World J. Gastrointest. Pharmacol. Ther., 7, 513, 10.4292/wjgpt.v7.i4.513 · DOI
  58. Ravanbakhsh, 2019, The role of mast cells in pediatric gastrointestinal disease, Ann. Gastroenterol., 32, 338
  59. Romantowski, 2020, How to diagnose Mast Cell Activation Syndrome? Practical considerations, Pol. Arch. Intern. Med., 130, 317
  60. Valent, P., Akin, C., Nedoszytko, B., Bonadonna, P., Hartmann, K., Niedoszytko, M., Brockow, K., Siebenhaar, F., Triggiani, M., and Arock, M. (2020). Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine. Int. J. Mol. Sci., 21. · DOI · Paper page
  61. Cimolai, 2020, Comparing histamine intolerance and non-clonal mast cell activation syndrome, Intest. Res., 18, 134, 10.5217/ir.2019.00087 · DOI
  62. Yang, 2010, Genetics of caffeine consumption and responses to caffeine, Psychopharmacology, 211, 245, 10.1007/s00213-010-1900-1 · DOI
  63. Morozova, 2014, Genetics and genomics of alcohol sensitivity, Mol. Genet. Genom., 289, 253, 10.1007/s00438-013-0808-y · DOI
  64. Szilagyi, A., and Ishayek, N. (2018). Lactose Intolerance, Dairy Avoidance, and Treatment Options. Nutrients, 10. · DOI
  65. Rezaie, 2017, Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus, Am. J. Gastroenterol., 112, 775, 10.1038/ajg.2017.46 · DOI
  66. Porzi, M., Burton-Pimentel, K.J., Walther, B., and Vergères, G. (2021). Development of personalized nutrition: Applications in lactose intolerance diagnosis and management. Nutrients, 13. · DOI
  67. Bayless, 2017, Lactase Non-persistence and Lactose Intolerance, Curr. Gastroenterol. Rep., 19, 23, 10.1007/s11894-017-0558-9 · DOI · Paper page
  68. Materna, 2013, Fructose and lactose intolerance and malabsorption testing: The relationship with symptoms in functional gastrointestinal disorders, Aliment. Pharmacol. Ther., 37, 1074, 10.1111/apt.12306 · DOI
  69. Berg, 2015, Self-reported dietary fructose intolerance in irritable bowel syndrome: Proposed diagnostic criteria, World J. Gastroenterol., 21, 5677, 10.3748/wjg.v21.i18.5677 · DOI
  70. Fedewa, 2013, Dietary Fructose Intolerance, Fructan Intolerance and FODMAPs, Curr. Gastroenterol. Rep., 16, 370, 10.1007/s11894-013-0370-0 · DOI
  71. Fassio, F., Facioni, M.S., and Guagnini, F. (2018). Lactose Maldigestion, Malabsorption, and Intolerance: A Comprehensive Review with a Focus on Current Management and Future Perspectives. Nutrients, 10. · DOI
  72. Olesen, 2017, Predictors of response to a low-FODMAP diet in patients with functional gastrointestinal disorders and lactose or fructose intolerance, Aliment. Pharmacol. Ther., 45, 1094, 10.1111/apt.13978 · DOI
  73. Halmos, 2014, A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome, Gastroenterology, 146, 67, 10.1053/j.gastro.2013.09.046 · DOI · Paper page
  74. Catassi, 2015, Diagnosis of Non-Celiac Gluten Sensitivity (NCGS): The Salerno Experts’ Criteria, Nutrients, 7, 4966, 10.3390/nu7064966 · DOI
  75. Taraghikhah, N., Ashtari, S., Asri, N., Shahbazkhani, B., Al-Dulaimi, D., Rostami-Nejad, M., Rezaei-Tavirani, M., Razzaghi, M.R., and Zali, M.R. (2020). An updated overview of spectrum of gluten-related disorders: Clinical and diagnostic aspects. BMC Gastroenterol., 20. · DOI
  76. Skypala, 2015, Sensitivity to food additives, vaso-active amines and salicylates: A review of the evidence, Clin. Transl. Allergy, 5, 34, 10.1186/s13601-015-0078-3 · DOI
  77. Andreozzi, 2019, Hypersensitivity reactions to food and drug additives: Problem or myth?, Acta Bio-Med. Atenei Parm., 90, 80
  78. Zanfirescu, 2019, A Review of the Alleged Health Hazards of Monosodium Glutamate, Compr. Rev. Food Sci. Food Saf., 18, 1111, 10.1111/1541-4337.12448 · DOI
  79. Kęszycka, P., Lange, E., and Gajewska, D. (2021). Effectiveness of Personalized Low Salicylate Diet in the Management of Salicylates Hypersensitive Patients: Interventional Study. Nutrients, 13. · DOI
  80. Muthukumar, 2020, Food and food products associated with food allergy and food intolerance—An overview, Food Res. Int., 138, 109780, 10.1016/j.foodres.2020.109780 · DOI
  81. Bahna, 2018, The dilemma of allergy to food additives, Allergy Asthma Proc., 39, 3, 10.2500/aap.2018.39.4092 · DOI
  82. O’Brien, L., Wall, C., Wilkinson, T., and Gearry, R. (2021). What Are the Pearls and Pitfalls of the Dietary Management for Chronic Diarrhoea?. Nutrients, 13. · DOI
  83. Black, 2020, Functional gastrointestinal disorders: Advances in understanding and management, Lancet, 396, 1664, 10.1016/S0140-6736(20)32115-2 · DOI · Paper page

Cited by

Sorted by citations

See all 5

Metadata

Authors
Kanikowska, A., Janisz, S., Mańkowska-Wierzbicka, D., Gabryel, M., Dobrowolska, A., & Eder, P.
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2022-12-09
Volume
11
Issue
24
Pages
7326
ISSN
2077-0383
DOI
10.3390/jcm11247326
PMC
PMC9784954
Cited by
5
References
6
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review